Janssen COVID-19 Vaccine

Chemical NameJanssen COVID-19 Vaccine
Dosage FormInjection (intramuscular; 0.5mL)
Drug ClassVaccines
SystemRespiratory
CompanyJanssen Pharmaceuticals
Approval Year2022

Indication

  • Authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older
Last updated on 4/23/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Janssen COVID-19 Vaccine Prescribing Information.2022Janssen Biotech, Inc., Horsham, PA